Widespread Distribution of a COVID-19 Vaccine Could Take As Long as 2024

Although it is increasingly likely that one of the COVID-19 vaccines currently being tested will be approved or receive Emergency Use Authorization (EUA) before the end of the year, experts are increasingly warning that widespread distribution may take a much longer time. Recently, Adar Poonawalla, chief executive officer of the Serum Institute of India, told the Financial Times that drug companies were not scaling up manufacturing capacity fast enough to vaccinate the entire global population.